title: In vivo production of mineralised tissue pieces for clinical use: a qualitative pilot study using human dental pulp cell.
abstract: Numerous previous studies have investigated the production of mineralised tissues by transplanting human dental pulp cells with calcium based scaffolds. The potential of alternative setups remains largely uninvestigated, therefore in this study, human dental pulp cells were encapsulated into non-calcium based biomaterial - self-assembling peptide nano-fibre hydrogel. The cell-gel constructs were cultured in full medium for 2 weeks. Then they were cultured in full medium supplemented with β-glycerophosphate, dexamethasone and l-ascorbic acid for 2 more weeks. These cell-gel constructs and plain-gel constructs (with no cells) were transplanted subcutaneously into five nude mice. The gel constructs were retrieved 4 weeks after surgery. The plain-gel constructs were all completely resorbed with no new tissue formation. The cell-gel constructs were transformed into tissue pieces that were mineralised and contained blood capillaries. Immunohistochemistry analysis confirmed the expression of multiple bone markers (osteopontin, osteocalcin, osteonectin and parathyroid hormone receptor) in these tissue pieces. Computerised analysis of the contact radiographs gave the mean radio-opaque area percentage as 78% (N=5, P<0.001 compared with the 0% of the control). The results demonstrate good prospects for using human dental pulp cell plus self-assembling peptide nano-fibre hydrogel to produce mineralised tissue pieces for clinical use.
authors.affiliation: Faculty of Dentistry, University of Hong Kong, Department of Health, The Government of HKSAR, Hong Kong.
authors.forename: B
authors.initials: B
authors.lastname: Chan
authors.forename: R W K
authors.initials: RW
authors.lastname: Wong
authors.forename: B
authors.initials: B
authors.lastname: Rabie
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D001205:Ascorbic Acid / Q000494:pharmacology; D002113:Calcification, Physiologic / Q000502:physiology*; D002196:Capillaries / Q000473:pathology; D018929:Cell Culture Techniques; D002470:Cell Survival; D003470:Culture Media; D003782:Dental Pulp / Q000166:cytology* / Q000187:drug effects; D003907:Dexamethasone / Q000494:pharmacology; D005938:Glucocorticoids / Q000494:pharmacology; D005994:Glycerophosphates / Q000494:pharmacology; D006801:Humans; D020136:Hydrogel, Polyethylene Glycol Dimethacrylate / Q000737:chemistry; D051379:Mice; D008819:Mice, Nude; D057139:Nanofibers / Q000737:chemistry; D015675:Osteocalcin / Q000032:analysis; D015676:Osteonectin / Q000032:analysis; D053495:Osteopontin / Q000032:analysis; D010455:Peptides / Q000737:chemistry; D010865:Pilot Projects; D044168:Receptor, Parathyroid Hormone, Type 1 / Q000032:analysis; D013234:Stem Cells / Q000187:drug effects / Q000502:physiology*; D040521:Subcutaneous Tissue / Q000601:surgery; D013997:Time Factors; D023822:Tissue Engineering / Q000379:methods*; D054457:Tissue Scaffolds / Q000737:chemistry
chemical_list: D000975:Antioxidants; D003470:Culture Media; D005938:Glucocorticoids; D005994:Glycerophosphates; D015676:Osteonectin; D010455:Peptides; C546681:RADA16-I; D044168:Receptor, Parathyroid Hormone, Type 1; D015675:Osteocalcin; D053495:Osteopontin; D020136:Hydrogel, Polyethylene Glycol Dimethacrylate; D003907:Dexamethasone; D001205:Ascorbic Acid; C031463:beta-glycerophosphoric acid